SCR7, a potent cancer therapeutic agent and a biochemical inhibitor of nonhomologous DNA end‐joining
Author:
Affiliation:
1. Institute of Bioinformatics and Applied Biotechnology Bangalore India
2. Manipal Academy of Higher Education Manipal India
3. Department of Biochemistry Indian Institute of Science Bangalore India
Publisher
Wiley
Subject
Cancer Research,Oncology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/cnr2.1341
Reference54 articles.
1. DNA Damage Repair and Response Proteins as Targets for Cancer Therapy
2. DNA Double-Strand Break Repair Inhibitors as Cancer Therapeutics
3. Tumor specific modulation of KU70/80 DNA binding activity in breast and bladder human tumor biopsies
4. Up-regulation of DNA-dependent protein kinase correlates with radiation resistance in oral squamous cell carcinoma
5. Harnessing DNA Double-Strand Break Repair for Cancer Treatment
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Topoisomerase Inhibitors and PIM1 Kinase Inhibitors Improve Gene Editing Efficiency Mediated by CRISPR-Cas9 and Homology-Directed Repair;Molecules;2024-06-18
2. Selective inhibition of DNA ligase IV provides additional efficacy to the treatment of anaplastic thyroid cancer;Frontiers in Oncology;2024-02-06
3. The ribonucleoprotein-mediated CRISPR–Cas9 system induces recurrent Aire gene mutations in contrast to the nickase expression vector in murinein vitroorin vivomodels;2023-10-13
4. Double‐strand DNA break repair: molecular mechanisms and therapeutic targets;MedComm;2023-10
5. Mutational Signatures in Gastric Cancer and Their Clinical Implications;Cancers;2023-07-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3